Trials / Terminated
TerminatedNCT01661387
A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)
A European, Multi-Centre, Multi-Country, Post-Authorisation, Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,258 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
As a post-approval requirement of the European Medicines Agency, this European patient post authorization safety study is an observational study being conducted to monitor the safety of long-term treatment with Plenadren and other glucocorticoid replacement therapies in routine clinical practice in patients with chronic adrenal insufficiency (primary or secondary).
Conditions
Timeline
- Start date
- 2012-08-07
- Primary completion
- 2020-10-31
- Completion
- 2020-10-31
- First posted
- 2012-08-09
- Last updated
- 2024-10-15
Locations
24 sites across 5 countries: Germany, Italy, Netherlands, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT01661387. Inclusion in this directory is not an endorsement.